Florence Esselin

Montpellier, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Journal: Mayo Clinic proceedings. Innovations, quality & outcomes

Published: August 04, 2026

Familial, neuropathological and cellular analysis identify ARPP21 as a major amyotrophic lateral sclerosis associated gene in French cohorts.

Familial, neuropathological and cellular analysis identify ARPP21 as a major amyotrophic lateral sclerosis associated gene in French cohorts.

Journal: Acta neuropathologica

Published: May 11, 2026

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Journal: Revue neurologique

Published: April 01, 2026

Correlations between peripheral neuropathy profiles and vascular skin lesions.

Correlations between peripheral neuropathy profiles and vascular skin lesions.

Journal: Journal of neurology

Published: February 05, 2026

Neuropathological analysis of an ALS patient carrying a SOD1 missense variant and a C9orf72 repeat expansion.

Neuropathological analysis of an ALS patient carrying a SOD1 missense variant and a C9orf72 repeat expansion.

Journal: Acta neuropathologica

Published: October 14, 2025

Phenotype-specific muscle proteomic profiling in titinopathies.

Phenotype-specific muscle proteomic profiling in titinopathies.

Journal: Acta neuropathologica communications

Published: September 12, 2025

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Journal: European journal of neurology

Published: May 01, 2025

Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy.

Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy.

Journal: European journal of neurology

Published: April 08, 2025

Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR).

Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR).

Journal: European journal of neurology

Published: April 03, 2025

Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis.

Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis.

Journal: Neurology

Published: February 26, 2025

Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.

Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.

Journal: Stem cell research

Published: February 21, 2025

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial.

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial.

Journal: Lancet (London, England)

Published: October 25, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026